4th Quarter - Report

RYAN MACKINNON VASAPOLI AND BERZOK, LLP for GENENTECH

Period 4th Quarter 2013 Filed Apr 29, 2014 Signed by Mr. Thomas M. Ryan, Managing Partner

Official filing
Firm
RYAN MACKINNON VASAPOLI AND BERZOK, LLP
Client
GENENTECH
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the implementation of the follow-on biologics provisions in P.L. 111-148- "Patient Protection and Affordable Care Act".

LobbyistCovered position, as disclosed
MATTHEW BERZOK LD, Chief Counsel, LA Rep. Stupak & Deutsch
NICK KOLOVOS LA Rep. Anna Eshoo (D-California)
JEFF MACKINNON LD & LA Rep. Joe Barton (R-Texas)
JEFFERY C MORTIER Prof Staff on E&C Cmte and LA Rep Whitfield
THOMAS RYAN —
JOSEPH V VASAPOLI Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: Food & Drug Administration (FDA); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Concerns regarding Meicare payment policies for Part B drugs. Issues related to the 340B Drug discount program.

LobbyistCovered position, as disclosed
MATTHEW BERZOK LD, Chief Counsel, LA Rep. Stupak & Deutsch
NICK KOLOVOS LA Rep. Anna Eshoo (D-California)
JEFF MACKINNON LD & LA Rep. Joe Barton (R-Texas)
JEFFERY C MORTIER Prof Staff on E&C Cmte and LA Rep Whitfield
THOMAS RYAN —
JOSEPH V VASAPOLI Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Food & Drug Administration (FDA)

Pharmacy PHA

Monitor Drug Safety and pedigree legislation. Monitor legislation and oversight on compounding pharmacies.

LobbyistCovered position, as disclosed
MATTHEW BERZOK LD, Chief Counsel, LA Rep. Stupak & Deutsch
NICK KOLOVOS LA Rep. Anna Eshoo (D-California)
JEFF MACKINNON LD & LA Rep. Joe Barton (R-Texas)
JEFFERY C MORTIER Prof Staff on E&C Cmte and LA Rep Whitfield
THOMAS RYAN —
JOSEPH V VASAPOLI Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.